Difference between revisions of "Parathyroid hyperplasia"

From Libre Pathology
Jump to navigation Jump to search
 
(5 intermediate revisions by the same user not shown)
Line 36: Line 36:
*Common cause of [[hyperparathyroidism]].  
*Common cause of [[hyperparathyroidism]].  
*Usually associated with [[chronic renal failure]].
*Usually associated with [[chronic renal failure]].
*May be syndromic - chief cell hyperplasia - associated with [[MEN 1]], [[MEN 2A]].<ref>URL: [http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970475-2 http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970475-2]. Accessed on: 29 July 2010.</ref>
*May be syndromic - chief cell hyperplasia - associated with [[MEN 1]], [[MEN 2A]].<ref>URL: [http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970475-2 http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970475-2]. Accessed on: 29 July 2010.</ref> ‡
 
Treatment:
*Surgical removal of all parathyroid glands & re-implantation of half of one parathyroid in the forearm.
 
Note: <br>
‡ MEN 1 and MEN 2A are often described as causing parathyroid hyperplasia; more correctly, it is thought these are actually multiple parathyroid adenomas.<ref name=pmid15490065>{{cite journal |authors=Doherty GM, Lairmore TC, DeBenedetti MK |title=Multiple endocrine neoplasia type 1 parathyroid adenoma development over time |journal=World J Surg |volume=28 |issue=11 |pages=1139–42 |date=November 2004 |pmid=15490065 |doi=10.1007/s00268-004-7560-8 |url=}}</ref>


==Gross==
==Gross==
Line 47: Line 53:
**Increased parenchymal cells.   
**Increased parenchymal cells.   
***Chief cells - usually predominant.<ref name=pmid8090603/>  
***Chief cells - usually predominant.<ref name=pmid8090603/>  
***"Water-clear" cells - may not be apparent:<ref name=pmid7487410/>
***"Water-clear" cells:
****Abundant foamy or granular cytoplasm.
****Abundant foamy or granular cytoplasm.<ref name=pmid7487410/>
****Mild [[nuclear pleomorphism]].
****Mild [[nuclear pleomorphism]].
****May not be present or apparent.
***Other parenchymal cells include: oxyphil cells and transitional oxyphil cells.
***Other parenchymal cells include: oxyphil cells and transitional oxyphil cells.


Line 68: Line 75:
Image: Parathyroid hyperplasia -- high mag.jpg | PA - high mag. (WC)
Image: Parathyroid hyperplasia -- high mag.jpg | PA - high mag. (WC)
</gallery>
</gallery>
====www====
*[https://www.flickr.com/photos/jian-hua_qiao_md/13138532173 Water clear cells in hyperplasia (flicker.com)].


==Sign out==
==Sign out==

Latest revision as of 21:53, 6 April 2022

Parathyroid hyperplasia
Diagnosis in short

Parathyroid hyperplasia. H&E stain.

LM hypercellular - usu. chief cell predominant, decreased adipose tissue, +/-"water-clear" cells (cells with abundant granular/foamy cytoplasm, mild nuclear pleomorphism)
LM DDx parathyroid adenoma, parathyroid carcinoma
Gross all parathyroid glands are enlarged
Site parathyroid gland

Associated Dx chronic renal failure
Syndromes MEN 1, MEN 2A

Prevalence uncommon
Blood work elevated PTH, +/-elevated calcium
Clin. DDx parathyroid adenoma
Treatment surgical removal of all parathyroid glands & re-implantation of half of one parathyroid in the forearm

Parathyroid hyperplasia is an abnormal proliferation of the parathyroid glands and a relatively common cause of hyperparathyroidism that is typically associated with chronic renal failure.[1]

General

Treatment:

  • Surgical removal of all parathyroid glands & re-implantation of half of one parathyroid in the forearm.

Note:
‡ MEN 1 and MEN 2A are often described as causing parathyroid hyperplasia; more correctly, it is thought these are actually multiple parathyroid adenomas.[3]

Gross

  • Parathyroid gland enlargement - classically all parathyroid glands are involved; however, some may be spared making it difficult to differentiate this from parathyroid adenoma.[4]

Microscopic

Features:

  • Hyperplastic/hypercellular appearance:
    • Decreased adipose tissue.[5]
    • Increased parenchymal cells.
      • Chief cells - usually predominant.[5]
      • "Water-clear" cells:
      • Other parenchymal cells include: oxyphil cells and transitional oxyphil cells.

Note:

  • Generally, it is impossible to discern between parathyroid adenomas and parathyroid hyperplasias by histology alone.[7]
    • One requires information of the size of the other glands to make the diagnosis.
  • Water-clear cells may be seen in an adenoma.[6]

DDx:

Images

www

Sign out

Clinical history is suggestive

A. Right Superior Parathyroid, Excision:
- Parathyroid tissue compatible with hyperplasia.

B. Right Inferior Parathyroid, Excision:
- Parathyroid tissue compatible with hyperplasia.

C. Portion of Left Inferior Parathyroid, Excision:
- Parathyroid tissue compatible with hyperplasia.

D. Left Superior Parathyroid, Excision:
- Parathyroid tissue compatible with hyperplasia.

See also

References

  1. Jamal, SA.; Miller, PD.. "Secondary and tertiary hyperparathyroidism.". J Clin Densitom 16 (1): 64-8. doi:10.1016/j.jocd.2012.11.012. PMID 23267748.
  2. URL: http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970475-2. Accessed on: 29 July 2010.
  3. Doherty GM, Lairmore TC, DeBenedetti MK (November 2004). "Multiple endocrine neoplasia type 1 parathyroid adenoma development over time". World J Surg 28 (11): 1139–42. doi:10.1007/s00268-004-7560-8. PMID 15490065.
  4. Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon (2009). Robbins and Cotran pathologic basis of disease (8th ed.). Elsevier Saunders. pp. 1128. ISBN 978-1416031215.
  5. 5.0 5.1 Yong, JL.; Vrga, L.; Warren, BA. (Apr 1994). "A study of parathyroid hyperplasia in chronic renal failure.". Pathology 26 (2): 99-109. PMID 8090603.
  6. 6.0 6.1 Grenko, RT.; Anderson, KM.; Kauffman, G.; Abt, AB. (Nov 1995). "Water-clear cell adenoma of the parathyroid. A case report with immunohistochemistry and electron microscopy.". Arch Pathol Lab Med 119 (11): 1072-4. PMID 7487410.
  7. Taxy, J.; Husain, A; Montag, A. (2009). Biopsy Interpretation: The Frozen Section (1st ed.). Lippincott Williams & Wilkins. pp. 191. ISBN 978-0781767798.